On 29 March 2012, the UK government launched a new online research service that will give life sciences companies unprecedented access to large sets of anonymised NHS patient data. The Clinical Practice Research Datalink ("CPRD") is managed by the UK Medicines and Healthcare products Regulatory Agency ("MHRA") and is part funded by the NHS National Institute for Health Research ("NIHR").
This new e-health research offering is a key part of the
government's 'Plan for Growth'. The CPRD is
expected to provide novel and powerful ways in which clinical
trials can be undertaken, develop new treatments for patients
faster and attract investment in the UK's life sciences sector
and economy.
The CPRD is apparently the world's largest computerised
database of anonymised longitudinal medical records from primary
care that is linked with other healthcare data. CPRD services
are designed to maximise the way anonymised NHS clinical data (e.g.
from patients suffering with conditions like cancer and diabetes)
can be linked to enable many types of observational research and
deliver research outputs that are beneficial to improving and
safeguarding public health.
The MHRA says the CPRD will be able to initiate "new surveillance methodologies helping all parties, including pharma companies, meet the public health needs of knowing about real world safety, effectiveness and the benefit-risk relationship".
This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to www.law-now.com/law-now/mondaq
Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.
The original publication date for this article was 04/04/2012.
